![Michael Morrissey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 31/07/2026
Michael Morrissey is Executive VP & Head-Global Technical Operations at Incyte Corp.
since 2019.
Previously, Mr. Morrissey was Vice President & Head-Technical Operations at Celgene International, Inc. Mr. Morrissey completed undergraduate studies at the University of London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INCYTE CORPORATION 0,02 % | 23/07/2026 | 34.065 ( 0,02 % ) | 4 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INCYTE CORPORATION | Director Técnico/Científico/I+D | 01/01/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
Celgene International, Inc. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Celgene International, Inc. | |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
